Answers are grounded in this paper and cite their sources.
Clinical lipid-based microbubbles suffer from limited in vivo persistence and rely on organic solvent-based formulations, restricting emerging ultrasound applications including blood-brain barrier opening and ultrasound localization microscopy. To address these limitations, we report the synthesis of a new class of water-soluble fluorinated biodegradable polymer based on poly(malic acid) grafted with different percentages of short fluorinated moieties. This material, distinct from previous fluorinated polymers, enables the direct formulation of perfluorocarbon-microbubbles in water, without any organic solvent nor the use of lipids. The fluorinated moieties confer exceptional interfacial properties to the polymer, enhancing gas-shell interactions, leading to improved stability compared to the commercial lipid agent SonoVue and ultrasound responsiveness. In vivo, decafluorobutane polymer-stabilized microbubbles exhibit prolonged circulation, achieving a fourfold increase in hepatic mean transit time in mice (326 vs. 75 s) and a twofold increase in cerebral half-life in rats assessed by ultrasound localization microscopy (83 vs. 46 s). Safe and effective BBB-opening was achieved at mechanical indices of 0.25 and above, without detectable brain damage. By combining solvent-free formulation, lipid-free composition, tunable fluorination, and improved in vivo persistence, fluorinated poly(malic acid) microbubbles represent a promising and robust alternative to SonoVue for contrast imaging and BBB-opening applications.
No takes yet. Share an insight, caveat, or question.
Spitzlei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: